Meng‐chao Wang

686 total citations
12 papers, 515 citations indexed

About

Meng‐chao Wang is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Meng‐chao Wang has authored 12 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Meng‐chao Wang's work include Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (3 papers). Meng‐chao Wang is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (3 papers). Meng‐chao Wang collaborates with scholars based in China, South Korea and United States. Meng‐chao Wang's co-authors include Yuan Yang, Weiping Zhou, Gang Huang, Weiping Zhou, Ze‐Ya Pan, Wan Yee Lau, Pengpeng Li, Linghao Zhao, Zhenguang Wang and Hui Liu and has published in prestigious journals such as Hepatology, Annals of Surgery and Scientific Reports.

In The Last Decade

Meng‐chao Wang

12 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng‐chao Wang China 11 303 267 149 125 70 12 515
Xiaoran Long China 10 338 1.1× 309 1.2× 179 1.2× 131 1.0× 39 0.6× 14 575
Xieju Xie China 7 154 0.5× 112 0.4× 127 0.9× 108 0.9× 107 1.5× 10 350
Jiongjiong Lu China 13 334 1.1× 301 1.1× 102 0.7× 87 0.7× 37 0.5× 20 498
Shima Mimura Japan 10 325 1.1× 173 0.6× 74 0.5× 81 0.6× 146 2.1× 41 495
Kongying Lin China 12 159 0.5× 186 0.7× 206 1.4× 123 1.0× 96 1.4× 48 466
Gao‐Min Liu China 9 267 0.9× 232 0.9× 79 0.5× 78 0.6× 87 1.2× 16 461
Xiaogeng Deng China 10 284 0.9× 241 0.9× 79 0.5× 48 0.4× 74 1.1× 20 436
Fudong Lv China 9 159 0.5× 102 0.4× 84 0.6× 88 0.7× 92 1.3× 13 312
Kaijun Huang China 7 330 1.1× 231 0.9× 102 0.7× 48 0.4× 64 0.9× 19 478

Countries citing papers authored by Meng‐chao Wang

Since Specialization
Citations

This map shows the geographic impact of Meng‐chao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐chao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐chao Wang more than expected).

Fields of papers citing papers by Meng‐chao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐chao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐chao Wang. The network helps show where Meng‐chao Wang may publish in the future.

Co-authorship network of co-authors of Meng‐chao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐chao Wang. A scholar is included among the top collaborators of Meng‐chao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐chao Wang. Meng‐chao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Yang, Yun, Meng‐chao Wang, Tian Tao, et al.. (2020). A High Preoperative Platelet-Lymphocyte Ratio Is a Negative Predictor of Survival After Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Study. Frontiers in Oncology. 10. 576205–576205. 18 indexed citations
3.
Yu, Jian, Meng‐chao Wang, Xinggang Guo, et al.. (2019). Plasma circular RNA panel to diagnose hepatitis B virus‐related hepatocellular carcinoma: A large‐scale, multicenter study. International Journal of Cancer. 146(6). 1754–1763. 90 indexed citations
4.
Ding, Wenbin, Meng‐chao Wang, Jianing Zhang, et al.. (2019). Novel insights of HBV RNA in hepatitis B virus pathogenesis and clinical application. Hepatoma Research. 2019. 1 indexed citations
5.
Zheng, Hao, Yuan Yang, Yonggang Hong, et al.. (2019). Tropomodulin 3 modulates EGFR‐PI3K‐AKT signaling to drive hepatocellular carcinoma metastasis. Molecular Carcinogenesis. 58(10). 1897–1907. 31 indexed citations
6.
Lin, Hui, Zhiping Huang, Jiao Liu, et al.. (2018). MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN. Scientific Reports. 8(1). 10461–10461. 60 indexed citations
7.
Yu, Lingxiang, Bolun Zhang, Yuan Yang, et al.. (2018). Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models. Oncology Reports. 41(1). 257–269. 42 indexed citations
8.
Huang, Gang, Pengpeng Li, Wan Yee Lau, et al.. (2018). Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels. Annals of Surgery. 268(6). 943–954. 94 indexed citations
9.
Ni, Jun-sheng, Hao Zheng, Zhiping Huang, et al.. (2018). MicroRNA‑197‑3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma. Oncology Letters. 17(2). 2317–2327. 48 indexed citations
10.
Zheng, Hao, Yuan Yang, Meng‐chao Wang, et al.. (2016). Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy. Surgical Oncology. 25(3). 171–177. 11 indexed citations
11.
Zheng, Hao, Yuan Yang, Jun Han, et al.. (2016). TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling. Scientific Reports. 6(1). 37070–37070. 52 indexed citations
12.
Chen, Fu, Shu‐Shen Liu, Yu Mo, Rui Qu, & Meng‐chao Wang. (2015). Blocking the entrance of AMP pocket results in hormetic stimulation of imidazolium-based ionic liquids to firefly luciferase. Chemosphere. 132. 108–113. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026